Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2015 9
2016 4
2017 5
2018 5
2019 2
2020 1
2022 1
2023 1
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme ('ENABLE 1.5') - study protocol.
Mandi H, Asogun D, Ayodeji O, Azuogu BN, Camacho A, Fischer W, Fulton R, Grant DS, Günther S, Ithete N, Illori E, Jan K, Kagia C, Martens N, Menon S, Ndiaye A, Ndifon M, Nsaibirni R, Ntiri M, Oloo P, Okogbenin S, Penfold S, Sankawulo-Ricks M, Sillah M, Suykerbuyk P, Tornieporth N, Vielle NJ, Williams M, Wohl D, Xie F, Yimer S, Breugelmans JG. Mandi H, et al. Among authors: camacho a. BMJ Public Health. 2025 Jul 31;3(2):e001960. doi: 10.1136/bmjph-2024-001960. eCollection 2025. BMJ Public Health. 2025. PMID: 40756165 Free PMC article.
Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the Congo.
Brindle HE, Tetsa-Tata D, Edwards T, Choi EM, Kasonia K, Aboubacar S, Mambula G, Kavunga-Membo H, Grais R, Johnson J, Bausch DG, Muyembe-Tamfum JJ, Ama IS, Lees S, Watson-Jones D, Camacho A, Roberts CH. Brindle HE, et al. Among authors: camacho a. PLOS Glob Public Health. 2025 May 2;5(5):e0004487. doi: 10.1371/journal.pgph.0004487. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40315243 Free PMC article.
Evaluation of a decentralised model of care on case isolation and patient outcomes during the 2018-20 Ebola outbreak in the Democratic Republic of the Congo: a retrospective observational study.
Barks PM, Camacho A, Newport T, Ribeiro F, Ahuka-Mundeke S, Kitenge R, Nsio J, Coulborn RM, Grellety E. Barks PM, et al. Among authors: camacho a. Lancet Glob Health. 2025 May;13(5):e931-e941. doi: 10.1016/S2214-109X(25)00011-7. Epub 2025 Mar 25. Lancet Glob Health. 2025. PMID: 40154517 Free article.
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN, Fischer WA 2nd, Garry RF, Grant DS, Happi C, N'Faly M, Olayinka A, Samuels R, Sibley J, Wohl DA, Accrombessi M, Adetifa I, Annibaldis G, Camacho A, Dan-Nwafor C, Deha ARE, DeMarco J, Duraffour S, Goba A, Grais R, Günther S, Honvou ÉJJP, Ihekweazu C, Jacobsen C, Kanneh L, Momoh M, Ndiaye A, Nsaibirni R, Okogbenin S, Ochu C, Ogbaini E, Logbo ÉPMA, Sandi JD, Schieffelin JS, Verstraeten T, Vielle NJ, Yadouleton A, Yovo EK; Enable Protocol authorship group. Penfold S, et al. Among authors: camacho a. PLoS One. 2025 Jan 14;20(1):e0317720. doi: 10.1371/journal.pone.0317720. eCollection 2025. PLoS One. 2025. PMID: 39808605 Free PMC article.
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches).
Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM. Watson CH, et al. Among authors: camacho a. BMC Med. 2024 Nov 7;22(1):523. doi: 10.1186/s12916-024-03726-z. BMC Med. 2024. PMID: 39511527 Free PMC article.
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.
Choi EM, Kasonia K, Kavunga-Membo H, Mukadi-Bamuleka D, Soumah A, Mossoko Z, Edwards T, Tetsa-Tata D, Makarimi R, Toure O, Mambula G, Brindle H, Camacho A, Connor NE, Mukadi P, McLean C, Keshinro B, Gaddah A, Robinson C, Luhn K, Foster J, Roberts CH, Johnson JE, Imbault N, Bausch DG, Grais RF, Watson-Jones D, Muyembe-Tamfum JJ; Tujiokowe Study Consortium. Choi EM, et al. Among authors: camacho a. Vaccines (Basel). 2024 Jul 23;12(8):828. doi: 10.3390/vaccines12080828. Vaccines (Basel). 2024. PMID: 39203955 Free PMC article.
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo.
Kavunga-Membo H, Watson-Jones D, Kasonia K, Edwards T, Camacho A, Mambula G, Tetsa-Tata D, Choi EM, Aboubacar S, Brindle H, Roberts C, Manno D, Faguer B, Mossoko Z, Mukadi P, Kakule M, Balingene B, Mapendo EK, Makarimi R, Toure O, Campbell P, Mousset M, Nsaibirni R, Ama IS, Janvier KK, Keshinro B, Cissé B, Sahani MK, Johnson J, Connor N, Lees S, Imbault N, Robinson C, Grais RF, Bausch DG, Muyembe-Tamfum JJ. Kavunga-Membo H, et al. Among authors: camacho a. Vaccines (Basel). 2024 Jul 23;12(8):825. doi: 10.3390/vaccines12080825. Vaccines (Basel). 2024. PMID: 39203952 Free PMC article.
Effectiveness of rVSV-ZEBOV vaccination during the 2018-20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study.
Meakin S, Nsio J, Camacho A, Kitenge R, Coulborn RM, Gignoux E, Johnson J, Sterk E, Musenga EM, Mustafa SHB; Epicentre-MSF EVD Working Group; Finger F, Ahuka-Mundeke S. Meakin S, et al. Among authors: camacho a. Lancet Infect Dis. 2024 Dec;24(12):1357-1365. doi: 10.1016/S1473-3099(24)00419-5. Epub 2024 Aug 20. Lancet Infect Dis. 2024. PMID: 39178866 Free article.
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN, Fischer WA 2nd, Garry RF, Grant DS, Happi C, N'Faly M, Olayinka A, Samuels R, Sibley J, Wohl DA, Accrombessi M, Adetifa I, Annibaldis G, Camacho A, Dan-Nwafor C, Deha ARE, DeMarco J, Duraffour S, Goba A, Grais R, Günther S, Honvou ÉJJP, Ihekweazu C, Jacobsen C, Kanneh L, Momoh M, Ndiaye A, Nsaibirni R, Okogbenin S, Ochu C, Ogbaini E, Logbo ÉPMA, Sandi JD, Schieffelin JS, Verstraeten T, Vielle NJ, Yadouleton A, Yovo EK; Enable Protocol authorship group. Penfold S, et al. Among authors: camacho a. PLoS One. 2023 Mar 30;18(3):e0283643. doi: 10.1371/journal.pone.0283643. eCollection 2023. PLoS One. 2023. PMID: 36996258 Free PMC article.
38 results